Arkolith/Insider Trading/ALZN/Form 4

Ault Milton C III

Director, 10% OwnerAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Aug 1, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$296K
Net Open-Market Flow
-$296K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 31, 2025Sell(S)100K$2.22$222K8K
Jul 30, 2025Conversion(C)100K$2.32$232K138K
Jul 30, 2025Sell(S)29K$2.51$74K108K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 30, 2025Conversion(C)232$1000.00$232K2K

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-011356) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML